Paired t test to compare the means of the two groups was highly significant ( p < 0.05 ) CONCLUSION : Cabergoline ( dostinex ) yields better results in decreasing the size of endometrioma , compared to LHRH-agonist by exerting antiangiogenic effects through vascular endothelial growth factor receptor-2 ( VEGFR-2 ) inactivation .